# PAREXEL Early Phase Clinical Unit, Baltimore, MD – FDA Inspections

Source: https://www.keypedia.com/companies/parexel-early-phase-clinical-unit/9748c7f3-64a9-490d-994d-e02b56d9d1d0

> Inspection records and compliance data for PAREXEL Early Phase Clinical Unit in Baltimore, Maryland. 1 FDA inspection on record, last inspected October 17, 2018.

---

## Details

- Name: PAREXEL Early Phase Clinical Unit
- FEI Number: 3005445577
- Business Operations: CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY
- Address Line 1: Medstar Harbor Hospital, 3001 S Hanover St Fl 7
- City: Baltimore
- State: Maryland
- Zip Code: 21225
- Country Name: United States
- Address: Medstar Harbor Hospital, 3001 S Hanover St Fl 7, Baltimore, Maryland 21225, United States
- Country: United States

## Related Documents

- [EIR - PAREXEL Early Phase Clinical Unit - 2018-10-27](https://www.keypedia.com/records/eir/parexel-early-phase-clinical-unit/7fdd6f45-c55d-485b-b17d-a83adcb2c4bb) — source: FDA, date: October 27, 2018
- FDA Inspection 1069420 - PAREXEL Early Phase Clinical Unit - 2018-10-17 — classification: No Action Indicated (NAI), source: FDA, date: October 17, 2018

## Related Companies

- [John J. Wroblewski, M.D.](https://www.keypedia.com/companies/john-j-wroblewski-md/152a4c6a-a7f1-43ad-a4ab-ab9c6b949452)
- [Leadiant Biosciences, Inc.](https://www.keypedia.com/companies/leadiant-biosciences-inc/96da3cf1-2605-43f0-b819-2daa4c14e527)
- [Medicine Invention Design Incorporation IRB](https://www.keypedia.com/companies/medicine-invention-design-incorporation-irb/e44eb96d-12cf-40b4-bad0-077b64ce61fd)
- [Reveragen Biopharma Inc.](https://www.keypedia.com/companies/reveragen-biopharma-inc/eaf70eaf-05c9-4025-b737-094553dcf19f)
- [Michael J. Polydefkis, M.D.](https://www.keypedia.com/companies/michael-j-polydefkis-md/f67f7603-94b9-4cb8-a7c5-90751ac1dce1)
- [Wanzhu Hou, CMD, MD (CN)](https://www.keypedia.com/companies/wanzhu-hou-cmd-md-cn/e1608fee-f767-4781-98f2-bc27db2520e2)
- [Tae H. Chung, M.D.](https://www.keypedia.com/companies/tae-h-chung-md/a30fcc9e-9af9-4eaf-ada7-d66551d9318e)
- [Warner Graham LLLP](https://www.keypedia.com/companies/warner-graham-lllp/b7f7ddcd-3aa8-4189-8732-9a854956ce5f)
- [National Cancer Institute, Cancer Therapy Evaluation Program](https://www.keypedia.com/companies/national-cancer-institute-cancer-therapy-evaluation-program/8cc7f4d2-3770-43d0-adba-33439499bb74)
- [National Cancer Institute (NCI)](https://www.keypedia.com/companies/national-cancer-institute-nci/07748909-4b54-4b85-b417-cee1bfa014cf)

## Related Officers

- [company_representative](https://www.keypedia.com/people/anna-zourabian-scalese/09111a25-6e60-4f48-b271-fcb2bc00dead)
- [company_representative](https://www.keypedia.com/people/d-ronald-goldwater/19359a51-1eb1-4787-9534-df8b8b23fc0d)